Adiponectin in Patients with Type 2 Diabetes Mellitus with Normal Body Weight
Journal Title: Міжнародний ендокринологічний журнал - Year 2015, Vol 1, Issue 65
Abstract
It was found that in patients with type 2 diabetes mellitus with normal body weight, average level of adiponectin (AN) in the blood plasma, in contrast to patients with overweight and obesity, is within reference range. At the same time, about half of them (54.5 %) had reduced AN level. The subgroup with decreased AN level differs by greater age of patients and duration of diabetes, as well as elevated levels of triglycerides and very low density lipoproteins, more frequent increase in waist circumference. However, in patients with type 2 diabetes mellitus and normal body weight we didn’t detect significant correlations between AH level and carbohydrate metabolism parameters — blood glucose and fasting insulin levels, index HOMA-IR. The findings show the necessity to promptly identify and correct lipid metabolism disorders in patients with type 2 diabetes mellitus with normal body weight.
Authors and Affiliations
O. A. Honcharova, V. I. Partskhaladze, I. M. Illinа
Keywords
Related Articles
- EP ID EP223169
- DOI -
- Views 47
- Downloads 0
Impact of Nonselective Laryngeal Reinnervation on Main Voice Characteristics
The possibility and long-term results of non-selective surgical reinnervation by primary and delayed anastomosis of recurrent laryngeal nerve (RLN) with the one of the peripheral neck nerve (proximal RLN part, main part...
News of endocrinology
.
Pathogenetic Aspects of Preventive Correction of Cognitive Impairment in Metabolic Syndrome
Objective. To study the opportunities to increase the efficiency of pathogenetic therapy in patients with chronic cerebrovascular diseases (CVD) (discirculatory encephalopathy, DE) on the background of metabolic syndrome...
The course of gastroduodenal bleedings in peptic ulcer patients with comorbid diabetes mellitus
Background. The prevalence of gastroduodenal ulcerative bleeding reaches 170 cases per 100,000 of the adult population, and the annual mortality due to them is 15 %. Comorbid diabetes mellitus (DM) is an independent risk...
The place of the third generation sulfonylurea glimepiride in modern therapy of type 2 diabetes mellitus
The article considers the pharmacological and clinical aspects of the use of glimepiride, a third generation sulfonylurea, in modern therapy of type 2 diabetes mellitus. The drug is characterized by proven efficacy and s...